Fisher症候群に合併したposterior reversible encephalopathy syndromeの1例

71歳女性.失調症状で発症し,第2病日に血圧上昇,視力障害,四肢脱力が出現し,第3病日に前医でステロイドパルス療法を施行された.第4病日に痙攣が出現し当院に転院した.搬送時,意識障害と高血圧,両側の視力低下と瞳孔散大,全外眼筋の麻痺と腱反射消失,顔面と四肢の筋力低下を認めた.MRIで左右頭頂葉と後頭葉の白質中心にT2高信号の病変を認めposterior reversible encephalopathy syndrome(PRES)と診断した.血清で抗GQ1b抗体陽性,髄液で蛋白細胞解離を確認し,症候と併せてFisher症候群と診断した.PRESは降圧療法で速やかに改善し,Fisher症候群は...

Full description

Saved in:
Bibliographic Details
Published in臨床神経学 Vol. 58; no. 1; pp. 45 - 48
Main Authors 横井, 克典, 川上, 治, 安藤, 哲朗
Format Journal Article
LanguageJapanese
Published 日本神経学会 2018
Subjects
Online AccessGet full text
ISSN0009-918X
1882-0654
DOI10.5692/clinicalneurol.cn-001089

Cover

Abstract 71歳女性.失調症状で発症し,第2病日に血圧上昇,視力障害,四肢脱力が出現し,第3病日に前医でステロイドパルス療法を施行された.第4病日に痙攣が出現し当院に転院した.搬送時,意識障害と高血圧,両側の視力低下と瞳孔散大,全外眼筋の麻痺と腱反射消失,顔面と四肢の筋力低下を認めた.MRIで左右頭頂葉と後頭葉の白質中心にT2高信号の病変を認めposterior reversible encephalopathy syndrome(PRES)と診断した.血清で抗GQ1b抗体陽性,髄液で蛋白細胞解離を確認し,症候と併せてFisher症候群と診断した.PRESは降圧療法で速やかに改善し,Fisher症候群は2か月の経過で緩徐に改善した.Fisher症候群にPRESを併発した機序を考察する.
AbstractList 71歳女性.失調症状で発症し,第2病日に血圧上昇,視力障害,四肢脱力が出現し,第3病日に前医でステロイドパルス療法を施行された.第4病日に痙攣が出現し当院に転院した.搬送時,意識障害と高血圧,両側の視力低下と瞳孔散大,全外眼筋の麻痺と腱反射消失,顔面と四肢の筋力低下を認めた.MRIで左右頭頂葉と後頭葉の白質中心にT2高信号の病変を認めposterior reversible encephalopathy syndrome(PRES)と診断した.血清で抗GQ1b抗体陽性,髄液で蛋白細胞解離を確認し,症候と併せてFisher症候群と診断した.PRESは降圧療法で速やかに改善し,Fisher症候群は2か月の経過で緩徐に改善した.Fisher症候群にPRESを併発した機序を考察する.
Author 横井, 克典
川上, 治
安藤, 哲朗
Author_xml – sequence: 1
  fullname: 横井, 克典
  organization: 安城更生病院神経内科
– sequence: 1
  fullname: 川上, 治
  organization: 安城更生病院神経内科
– sequence: 1
  fullname: 安藤, 哲朗
  organization: 安城更生病院神経内科
BookMark eNpVkMFKw0AYhBdRsNa-Q14g9d-km-wepVgViiIoeAt_NluTst2ETRR6MycFL96KJy_eBG8e7cukpa-hpYJ4mWFgZg7fHtk2uVGEOBS6LBDegdSZySRqo25trrvSuAAUuNgiLcq550LAetukBQDCFZRf75JOWWbxOjPBaa9FLgZZmSq7mj0s719W87emfl8-Py6-Ppt61tSvRV5Wyma5day6U_Znq5WjjFRFijovsEqnTjk1ic0nqqk_6GL-tE92RqhL1fn1NrkaHF32T9zh-fFp_3Dojr3AAxeFpCymIUiKcdgTLIGECeSJD4mQsS-p5CiCEYRShQn3aSAZohcmwPwReMJvk7PN77is8EZFhc0maKcR2iqTWkX_2USMR3Qt0kQbRn_FFG00Rv8bUhB1Dw
ContentType Journal Article
Copyright 2018 日本神経学会
Copyright_xml – notice: 2018 日本神経学会
DOI 10.5692/clinicalneurol.cn-001089
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1882-0654
EndPage 48
ExternalDocumentID article_clinicalneurol_58_1_58_cn_001089_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
OK1
P2P
RJT
ID FETCH-LOGICAL-j2620-a9c15b170c1ab7495d0d59a8d30d9cb3c1c8a96f07ce7d8316c5aa27d053f0293
ISSN 0009-918X
IngestDate Wed Sep 03 06:23:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2620-a9c15b170c1ab7495d0d59a8d30d9cb3c1c8a96f07ce7d8316c5aa27d053f0293
OpenAccessLink https://www.jstage.jst.go.jp/article/clinicalneurol/58/1/58_cn-001089/_article/-char/ja
PageCount 4
ParticipantIDs jstage_primary_article_clinicalneurol_58_1_58_cn_001089_article_char_ja
PublicationCentury 2000
PublicationDate 2018
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – year: 2018
  text: 2018
PublicationDecade 2010
PublicationTitle 臨床神経学
PublicationTitleAlternate 臨床神経学
PublicationYear 2018
Publisher 日本神経学会
Publisher_xml – name: 日本神経学会
References 1) Hinchey J, Chaves C, Appignanni B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
9) Etxeberria A, Lonneville S, Rutgers MP, et al. Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome. Rev Neurol 2012;168:283-286.
4) 日本高血圧学会高血圧治療ガイドライン作成委員会編.高血圧治療ガイドライン2014.東京:ライフサイエンス出版株式会社;2014. p. 110-111.
6) Stetefeld HR, Lehmann HC, Fink GR et al. Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller-Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome. J Stroke Cerebrovasc Dis 2014;23:423-425.
8) Rigamonti A, Basso F, Scaccabarozzi C, et al. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome: case report and review of the literature. J Peripher Nerv Syst 2012;17:356-360.
3) Mathy I, Gille M, Van Raemdonck F, et al. Neurological complications of intravenous immunoglobulin therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 1998;98:347-351.
5) Lewis M, Maddison P. Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome? J Neurol Neurosurg Psychiatry 2000;69:704.
7) Banakar BF, Pujar GS, Bhargava A, et al. Guillain-Barre syndrome with posterior reversible encephalopathy syndrome. J Neurosci Rural Pract 2014;5:63-65.
10) Lyu RK, Tang LM, Hsu WC, et al. Quantitative cardiovascular autonomic function study in Fisher syndrome. J Neurol Neurosurg Psychiatry 2002;73:333-335.
2) 大越教夫,吉沢和朗.薬剤性白質脳症.神経内科 2010;72:343-351.
References_xml – reference: 6) Stetefeld HR, Lehmann HC, Fink GR et al. Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller-Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome. J Stroke Cerebrovasc Dis 2014;23:423-425.
– reference: 2) 大越教夫,吉沢和朗.薬剤性白質脳症.神経内科 2010;72:343-351.
– reference: 8) Rigamonti A, Basso F, Scaccabarozzi C, et al. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome: case report and review of the literature. J Peripher Nerv Syst 2012;17:356-360.
– reference: 7) Banakar BF, Pujar GS, Bhargava A, et al. Guillain-Barre syndrome with posterior reversible encephalopathy syndrome. J Neurosci Rural Pract 2014;5:63-65.
– reference: 1) Hinchey J, Chaves C, Appignanni B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
– reference: 4) 日本高血圧学会高血圧治療ガイドライン作成委員会編.高血圧治療ガイドライン2014.東京:ライフサイエンス出版株式会社;2014. p. 110-111.
– reference: 5) Lewis M, Maddison P. Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome? J Neurol Neurosurg Psychiatry 2000;69:704.
– reference: 10) Lyu RK, Tang LM, Hsu WC, et al. Quantitative cardiovascular autonomic function study in Fisher syndrome. J Neurol Neurosurg Psychiatry 2002;73:333-335.
– reference: 3) Mathy I, Gille M, Van Raemdonck F, et al. Neurological complications of intravenous immunoglobulin therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 1998;98:347-351.
– reference: 9) Etxeberria A, Lonneville S, Rutgers MP, et al. Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome. Rev Neurol 2012;168:283-286.
SSID ssib000959814
ssib058494234
ssib002821941
ssib000940416
ssib002484599
ssib005879791
ssj0060813
Score 2.176247
Snippet 71歳女性.失調症状で発症し,第2病日に血圧上昇,視力障害,四肢脱力が出現し,第3病日に前医でステロイドパルス療法を施行された.第4病日に痙攣が出現し当院に転...
SourceID jstage
SourceType Publisher
StartPage 45
SubjectTerms Fisher症候群
posterior reversible encephalopathy syndrome
高血圧
高血圧性脳症
Title Fisher症候群に合併したposterior reversible encephalopathy syndromeの1例
URI https://www.jstage.jst.go.jp/article/clinicalneurol/58/1/58_cn-001089/_article/-char/ja
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 臨床神経学, 2018, Vol.58(1), pp.45-48
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1882-0654
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib000959814
  issn: 0009-918X
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR3LbtQwMCpFQlwQT_HWHvAxJQ87sY_2bkqFBFKlVuotSpxEZVXtrlbLAU7sCSQu3CpOXLghceNIf2Zb9TeYsZNstjwEFdpVlMTjyUzGY884nrHjPAITO4s1z1xeaurSMGdulseRG0ZVyJnnlYU2qy2eR1u79Oke21u7oLrRJbN8Q7_-ZVzJeaQK90CuGCX7D5JtkcINOAf5whEkDMe_knG9b3kSExET8OoTZhYuCLyjEiIpSUIwFYlUWCQ8wjlJKFEDolhdBBXrk80JxntMX4ynGM-C02gYVIWKP9nPDsa4dfGrNsFBgzjxDcKEcNU1c0nCkR7J8blKEi6RJAk0JIY2oLOPRXJAZDs1SJIIa0hpUEoiGMrfMAV_VZ8ovoSHK2B9YOA5PsTAR0QFRKkumAQCBRIF7MJbqdGKECEBXvSJXb7bzH_UnTW2VVNuaLeAsv8HVgwlgEyuDAYC-nqzszEMhbb_R4cD4227AwTjPymC7e1tIszabrAJQ8-OSCwSmOG2CXM1SUoPNvTIRWfcbp50Jt933ZrS1Sop46mPBz1KbdW0BdzPpukQfISLQQzWFi5M2O6Y2IJ6K1-WBRO88-U8oJwyseKC-93YZsZjES_zKYG9KsACp421E4FJ2e5WiC_TrpZDth__jmkw9obg-jTLJo0lt3PVuVK7YD1pGbvmrA2z686lZ_UikxvOtlWr08O3J28-nh59Xsy_nHx4d_z922J-uJh_atWkt1ST3qqa9Bo1Wcy_-sdH7286u5vJTn_LrXcecYe4QYObCe2z3I897UPPRQUrvIKJjBehVwidh9qH7k1ElRfrMi546EeaZVkQFzCkVR5Y0Lec9dF4VN52erzMfMHLChyPinp5lGkae1EQlPCrdEDvOE_sy0gnNr1Met4GcPe_YbrnXEZNszON95312fRl-QBs71n-0DSuHzIPv4A
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fisher%E7%97%87%E5%80%99%E7%BE%A4%E3%81%AB%E5%90%88%E4%BD%B5%E3%81%97%E3%81%9Fposterior+reversible+encephalopathy+syndrome%E3%81%AE1%E4%BE%8B&rft.jtitle=%E8%87%A8%E5%BA%8A%E7%A5%9E%E7%B5%8C%E5%AD%A6&rft.au=%E6%A8%AA%E4%BA%95%2C+%E5%85%8B%E5%85%B8&rft.au=%E5%B7%9D%E4%B8%8A%2C+%E6%B2%BB&rft.au=%E5%AE%89%E8%97%A4%2C+%E5%93%B2%E6%9C%97&rft.date=2018&rft.pub=%E6%97%A5%E6%9C%AC%E7%A5%9E%E7%B5%8C%E5%AD%A6%E4%BC%9A&rft.issn=0009-918X&rft.eissn=1882-0654&rft.volume=58&rft.issue=1&rft.spage=45&rft.epage=48&rft_id=info:doi/10.5692%2Fclinicalneurol.cn-001089&rft.externalDocID=article_clinicalneurol_58_1_58_cn_001089_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-918X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-918X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-918X&client=summon